Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
MannKind Corporation is seeking an Associate Director of Marketing for FUROSCIX in Burlington, MA. You will translate brand strategy into disciplined, high-impact commercial execution and drive omnichannel initiatives that engage customers and improve performance.
The role leads strategic planning through execution, partnering with Sales, Medical Affairs, Analytics, Legal, and agencies to optimize programs and allocate resources in a fast-paced, growing organization.
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.
Our employees are our greatest asset. We foster a close-knit, collaborative culture where every team member plays a vital role in our mission. We champion a rich blend of backgrounds, perspectives, and working styles as we work together to improve health outcomes and change lives.
MannKind is seeking an Associate Director, Marketing - FUROSCIX to help translate brand strategy into disciplined, high-impact commercial execution. This role will support the development and delivery of the integrated marketing plan, create consistent and differentiated messaging across field and digital channels, and advance omnichannel initiatives that drive customer engagement and business performance.
The Associate Director will lead assigned initiatives from strategic planning through execution, partnering closely with Sales, Training, Medical Affairs, Analytics, Legal, Regulatory, and agency partners. The role will use customer insights, market intelligence, and performance analytics to optimize programs, recommend resource allocation, and adapt plans as business needs evolve.
This role reports to the Director, Marketing.
With the spread of the coronavirus, many individuals are concerned about access to their medication supply. At this time, MannKind does not anticipate that the supply of its inhalable insulin Afrezza (insulin human) Inhalation Powder will be affected by the coronavirus.
We will continue to closely monitor our supply chain for potential impact to the supply of Afrezza. MannKind sources critical raw materials from suppliers in the United States and Europe and we remain in close communication with key suppliers to assure a reliable supply of insulin.
Our US manufacturing facility is fully operational and we are taking a number of steps to prevent any impact to our supplies. Afrezza is still readily available in U.S. pharmacies, and if needed, pharmacies can order additional supplies from wholesalers with expected delivery within 1-2 days. As the global situation evolves, we will continue to take the necessary steps to safeguard the reliable supply of Afrezza.